Health workers wear protective suits and face masks. Collection of swab samples by medical personnel at the drive-in testing center at San Filippo Neri Hospital in Roma, Italy, October 19, 2020.
Nourphoto | Nourphoto | Getty Images
LONDON – Covid-19 is likely to be as “local” as the annual flu virus, according to the UK’s chief scientific adviser.
“We can’t be sure, but I think we should really end the sterilized vaccine, which completely stops the infection, and possibly ulate the disease will spread and remain local, that’s my best assessment,” Patrick Vallans said in London on Monday. Told the strategy committee.
“Obviously as management gets better, you get vaccinated which reduces the chances of infection and the severity of the disease … After this it looks more like an annual flu than anything else and this could be the direction we end.” . ” He said.
He warned that vaccines against the new coronavirus – and a handful in phase clinical trials, according to the World Health Organization – were unlikely to eradicate the virus in any way.
“The idea of eradicating covid from anywhere is not appropriate, as it will come back,” he said, adding that there was only one human disease, which was “really eradicated” thanks to a really effective vaccine and that was smallpox.
Biotech companies and educational institutions around the world have joined forces to try to develop a vaccine against coronavirus at an alarming rate. On Monday, the deadly target of 40 million confirmed coronavirus cases worldwide was reached, and 1.1 million people died from the virus, according to data from Johns Hopkins University.
Historically, it took an average of 10 years to create a vaccine from scratch, says Vale Lens, and it never took less than five years.
“We are now in an extraordinary situation where there are at least eight vaccines that are in medical studies around the world … We will know in the next few months that we have a vaccine that really protects and how long they last. For protection,” he said. Said.
He added that there are a number of vaccines that produce an immune response and antibody response, but only stage 3 clinical trials will prove that they “really stop people from getting infected.” The safety profile of such vaccines will also be clarified and, since then, a “sensitive vaccination strategy” will be considered, Vallans said.
Vallans concluded that he does not believe there will be a vaccine available for widespread use in the community, at least until spring 2021.
.
